UMIN ID: UMIN000001650
Registered date:22/01/2009
A prospective,multicenter, randomized, parallel-group,open-label study of aripiprazole in the management of patients with schizophrenia
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Schizophrenia |
Date of first enrollment | 2009/01/01 |
Target sample size | 300 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Aripiprazole Standard control |
Outcome(s)
Primary Outcome | Preference of Medicine(POM) |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | 65years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Pregnant or breastfeeding women. Not noticed as schizophrenia. With diabetes. |
Related Information
Primary Sponsor | Department of Psychiatry, Graduate School of Medicine, Chiba University |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Graduate School of Medicine, Chiba University |
Secondary ID(s) |
Contact
public contact | |
Name | Tomihisa Niitsu |
Address | 1-8-1 Inohana, Chuo-ku, Chiba, Japan Japan |
Telephone | 043-226-2148 |
niitsu@chiba-u.jp | |
Affiliation | Graduate School of Medicine, Chiba University Department of Psychiatry |
scientific contact | |
Name | Masaomi Iyo |
Address | 1-8-1 Inohana, Chuo-ku, Chiba Japan |
Telephone | 043-226-2148 |
iyom@faculty.chiba-u.jp | |
Affiliation | Graduate School of Medicine, Chiba University Department of Psychiatry |